Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prime Medicine (PRME) Preferred Dividend Payments (2021 - 2022)

Prime Medicine (PRME) has disclosed Preferred Dividend Payments for 1 consecutive years, with $1.3 million as the latest value for Q4 2022.

  • For the quarter ending Q4 2022, Preferred Dividend Payments changed N/A year-over-year to $1.3 million, compared with a TTM value of $1.3 million through Sep 2023, down 93.04%, and an annual FY2022 reading of $20.2 million, up 16.83% over the prior year.
  • Preferred Dividend Payments was $1.3 million for Q4 2022 at Prime Medicine, down from $6.4 million in the prior quarter.
  • Across five years, Preferred Dividend Payments topped out at $6.4 million in Q3 2022 and bottomed at $1.3 million in Q4 2022.